Blog
EQS-News: MGI – Media and Games Invest SE: Directed issue of warrants as part of the relocation to Sweden to cover existing obligations
EQS-News: MGI – Media and Games Invest SE: Directed issue of warrants as part of the relocation to Sweden to cover existing obligations
Annual General Meeting of Schaffner Holding AG approves all proposals – Markus Heusser elected as new Chairman of the Board of Directors
Annual General Meeting of Schaffner Holding AG approves all proposals – Markus Heusser elected as new Chairman of the Board of Directors
Fuller, Smith & Turner PLC: Transaction in Own Shares
Fuller, Smith & Turner PLC: Transaction in Own Shares
Swiss Life successfully places Senior Bonds totalling CHF 600 million
Swiss Life successfully places Senior Bonds totalling CHF 600 million
Rights and Issues Investment Trust PLC: POS-Transaction in Own Shares
Rights and Issues Investment Trust PLC: POS-Transaction in Own Shares
EQS-Adhoc: KROMI Logistik AG: TGV sets cash payment for intended squeeze-out under stock corporation law at EUR 8.50 / Cash payment is higher than the calculated pro rata company value per share
EQS-Adhoc: KROMI Logistik AG: TGV sets cash payment for intended squeeze-out under stock corporation law at EUR 8.50 / Cash payment is higher than the calculated pro rata company value per share
LKE Haustechnik AG of Landquart becomes a company of the Burkhalter Group
LKE Haustechnik AG of Landquart becomes a company of the Burkhalter Group
Turkiye Garanti Bankasi A.S.: Coupon payment of Subordinated Debt Securities to Qualified Investors
Turkiye Garanti Bankasi A.S.: Coupon payment of Subordinated Debt Securities to Qualified Investors
Director/PDMR Shareholding
Director/PDMR Shareholding
EQS-News: SGT German Private Equity GmbH & Co. KGaA: SGT German Private Equity - Major shareholder SGT Capital LLC acquires more shares
EQS-News: SGT German Private Equity GmbH & Co. KGaA: SGT German Private Equity - Major shareholder SGT Capital LLC acquires more shares
Form 8.3 - The Vanguard Group, Inc.: Shaftesbury plc
Form 8.3 - The Vanguard Group, Inc.: Shaftesbury plc
Form 8.3 - The Vanguard Group, Inc.: RPS Group plc
Form 8.3 - The Vanguard Group, Inc.: RPS Group plc
Form 8.3 - The Vanguard Group, Inc.: Micro Focus International plc
Form 8.3 - The Vanguard Group, Inc.: Micro Focus International plc
Form 8.3 - The Vanguard Group, Inc.: Mediclinic International plc
Form 8.3 - The Vanguard Group, Inc.: Mediclinic International plc
Form 8.3 - The Vanguard Group, Inc.: Devro plc
Form 8.3 - The Vanguard Group, Inc.: Devro plc
Form 8.3 - The Vanguard Group, Inc.: Capital & Counties Properties plc
Form 8.3 - The Vanguard Group, Inc.: Capital & Counties Properties plc
Rights and Issues Investment Trust PLC: NAV-Net Asset Value(s)
Rights and Issues Investment Trust PLC: NAV-Net Asset Value(s)
Form 8.3 - The Vanguard Group, Inc.: Biffa plc
Form 8.3 - The Vanguard Group, Inc.: Biffa plc
Form 8.3 - The Vanguard Group, Inc.: AVEVA Group plc
Form 8.3 - The Vanguard Group, Inc.: AVEVA Group plc
Form 8.3 - The Vanguard Group, Inc.: Horizon Therapeutics plc
Form 8.3 - The Vanguard Group, Inc.: Horizon Therapeutics plc
Chelverton UK Dividend Trust plc: NAV-Net Asset Value(s)
Chelverton UK Dividend Trust plc: NAV-Net Asset Value(s)
EQS-News: Sernova and Evotec on Track to Initiate Clinical Testing of the First iPSC-Derived Islets in Cell Pouch as a Potential Functional Cure for Type 1 Diabetes
EQS-News: Sernova and Evotec on Track to Initiate Clinical Testing of the First iPSC-Derived Islets in Cell Pouch as a Potential Functional Cure for Type 1 Diabetes
EQS-Adhoc: Approval by the bondholders of ACCENTRO Real Estate AG’s 2020/2023 bond to the refinancing of the 2020/2023 bond
EQS-Adhoc: Approval by the bondholders of ACCENTRO Real Estate AG’s 2020/2023 bond to the refinancing of the 2020/2023 bond
EQS-Adhoc: alstria office REIT-AG: Portfolio valuation as per December 31, 2022 of EUR 4.6 bn
EQS-Adhoc: alstria office REIT-AG: Portfolio valuation as per December 31, 2022 of EUR 4.6 bn
EQS-News: BRAIN Biotech AG: BRAIN Group's Akribion Genomics business will prioritize the development of therapeutic applications within its CRISPR technology platform
EQS-News: BRAIN Biotech AG: BRAIN Group's Akribion Genomics business will prioritize the development of therapeutic applications within its CRISPR technology platform


